Three of the viruses — flu, COVID-19 and RSV — are respiratory viruses and spread from person to person through germ-filled ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...

The latest data released Friday from the Montana Department of Public Health and Human Services indicates four more people ...

Emily and Joey Spadafore watched helplessly as their 3-month-old son, Benjamin, battled RSV for a week in the hospital.

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

Most people will recover from viruses like the flu, COVID, and RSV without medical care, but some patients might need a trip ...

During winter, a lot of bugs get passed around, including RSV. Dr. Cynthia Brinson is the Medical Director, Principal Investigator and President of Central Texas Clinical Research, and she’s ...

The podcast released this week also features Dr. Andi Shane, the Children's Division Chief of Pediatric Infectious Diseases, ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

Advancements in prevention strategies against respiratory syncytial virus (RSV) are transforming pediatric care. Experts recommend the use of prophylactic monoclonal antibodies for immunizing infants.